Selective blockade of N-type calcium channels by levetiracetam - Test2 - elhamkhani - TriplyDB

Selective blockade of N-type calcium channels by levetiracetam

Selective blockade of N-type calcium channels by levetiracetam

http://www.wikidata.org/entity/Q28205214

about

sameAs

Levetiracetam monotherapy for epilepsy Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures Levetiracetam in the treatment of epilepsy The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism The neurobiology of antiepileptic drugs Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine Seletracetam (UCB 44212)The antiepileptic drug levetiracetam suppresses non-convulsive seizure activity and reduces ischemic brain damage in rats subjected to permanent middle cerebral artery occlusion Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112)A case of levetiracetam (Keppra) poisoning with clinical and toxicokinetic data.Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data.Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus.Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy.Region-specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoin.Recent and future advances in the treatment of status epilepticus Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation.Novel anticonvulsant medications in development.Pharmacotherapy of paediatric epilepsy.Levetiracetam Prevents Perforin Mediated Neuronal Injury Induced by Acute Cerebral Ischemia Reperfusion.Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects.Choosing antiepileptic drugs for developmentally normal children with specific epilepsy syndromes and behavioral disorders.Pharmacological treatment of childhood absence epilepsy.Voltage-gated calcium channels and idiopathic generalized epilepsies.The safety of levetiracetam.GABAA receptors, anesthetics and anticonvulsants in brain development.Levetiracetam in the treatment of childhood epilepsy.Truly "rational" polytherapy: maximizing efficacy and minimizing drug interactions, drug load, and adverse effects.Levetiracetam: a comprehensive review.Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited.Pharmacotherapy for children and adolescents with epilepsy.Overdose with levetiracetam: a case report and review of the literature.Effects of antiepileptic drugs on antioxidant and oxidant molecular pathways: focus on trace elements.Development of individualized medicine for epilepsy based on genetic information.Mechanisms of levetiracetam in the control of status epilepticus and epilepsy.The Role of Calcium Channels in Epilepsy.Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial.Drug-Resistant Epilepsy and Surgery.Levetiracetam as an adjunctive analgesic in neoplastic plexopathies: case series and commentary.The antihyperalgesic effect of levetiracetam in an inflammatory model of pain in rats: mechanism of action.

P2860

Q24201619-BDE9F9B4-DB19-4E1C-B945-6F4218E9A925 Q24650880-C931ADDD-1851-4DFB-B5CD-E74A6FB83F0E Q24656333-40601D30-A27B-4EB3-81D7-02BD7C95D59A Q26739054-FF33BFF7-097B-472F-8D57-51FE99FDB916 Q28267900-6DC0D301-D428-4A65-8D55-0B36FA8E6679 Q28269848-90711C34-67F9-4A0E-807D-F62E2285BC01 Q28281424-62D45777-C35B-4DF3-95D5-D498D2791DA9 Q28535091-D2DE1782-B5B3-4306-A1F5-F4ACD21BF30D Q30577314-CE7895EB-6527-4B87-A8E3-9E328ABBA7FF Q30758639-0F66C236-7E70-46F3-BD92-653933E56468 Q31110554-98B411D5-5D6A-437D-BE19-51A28B0A020D Q33569536-68EAF5DC-A5EB-499C-B3F2-91FCBFA50AC0 Q33621804-B8E1071E-00E7-4010-8AED-D6A90F87C483 Q34118114-6314C2CC-ACA9-41DB-932A-2032675A7BCF Q34409078-F4087EBF-D5FF-4FBB-9FC5-899530C174DF Q34540232-E694654C-75D1-4178-A293-F1F2EFFEB5E6 Q34974862-0500823C-B74D-4704-A1D9-AB286C73E330 Q35095171-6092778B-369D-40F9-82E3-A224948F39BF Q35802649-C45ABBFC-14E9-484E-9AC2-DF72BE4089CF Q35939580-8B19B25A-C645-435F-9155-019E69F2A05A Q35939596-AC881FAF-41D3-4CD0-914E-A8F02B415251 Q36511313-883C9220-C674-40CA-88E9-13C18B79271B Q36525559-F34CBCBF-9221-444A-80E9-8C022BDFFF1E Q36811528-9BF6E414-1F6F-470D-A07C-6C87A060A592 Q36917900-F9CCDE84-5DA1-4C03-8262-CF08D4898B6D Q37126800-D08B34F2-CEF7-43C8-8588-2FC3759EFAF4 Q37313454-59945177-1A0C-43E3-BA75-4500111A4263 Q37688063-A2A7EFBD-15F1-4D97-9463-43F53CDBD6E0 Q37823314-EB60C9AA-C4EA-43A7-A908-0A50C5C18B72 Q37826193-CCBCB353-27AE-44BC-A9BA-5B847BF5BFE9 Q38020951-5046EF3B-EC12-4AFF-8387-B4F5FA85A930 Q38098898-58D62E82-0016-4634-9F5F-ACCF23039603 Q38178326-923EDA1D-38B6-424D-AE1C-D227A13FD221 Q38189350-77259968-F73E-4122-9637-C9BC17D306EF Q38686593-01BCE01C-9766-4F97-9E67-BD4DF57067AC Q38752407-F0CEBBE4-3126-4DEA-BBED-FD29BD2377FD Q39274579-84287A5F-BA1D-433B-8E62-E873E3DC77F8 Q39285399-EDE7B78E-6A76-4DE4-861F-B3CA06099CD0 Q39368495-A2C6D711-9374-4845-9282-067F9CFFD0D7 Q41682239-2273C76C-93D0-41EC-9EB1-6A7CBE6D8807

P2860

Selective blockade of N-type calcium channels by levetiracetam

http://www.wikidata.org/entity/Q28205214

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Selective blockade of N-type calcium channels by levetiracetam

@ast

Selective blockade of N-type calcium channels by levetiracetam

@en

Selective blockade of N-type calcium channels by levetiracetam

@nl

type

label

Selective blockade of N-type calcium channels by levetiracetam

@ast

Selective blockade of N-type calcium channels by levetiracetam

@en

Selective blockade of N-type calcium channels by levetiracetam

@nl

prefLabel

Selective blockade of N-type calcium channels by levetiracetam

@ast

Selective blockade of N-type calcium channels by levetiracetam

@en

Selective blockade of N-type calcium channels by levetiracetam

@nl

P1433

Q28205214-26D8FA91-EE1C-4613-9654-5B6ED4A47E3B

P1476

Q28205214-E9C95C02-6FA3-410C-9B81-DBAC08DBB020

P2093

Q28205214-1593BD50-791B-44F7-8986-D0E9F90176ED

Q28205214-7D8B0A55-4908-4F77-9F45-4071CBB46012

Q28205214-DE1A4408-497F-496E-9004-189A5C6EBE90

P2860

Q28205214-0090F53B-9041-479E-BBDC-F943C995210B

Q28205214-08E7B510-5BB4-4872-A8E8-999FF3F30197

Q28205214-1517B2D3-1D24-44DF-9560-9BE8AFD6C8FF

Q28205214-1B5A1A39-2364-4CA1-A8AA-E847DA1BD311

Q28205214-24924EE1-96BA-4892-9032-A950BB39CCF8

Q28205214-25BFBEA1-A2A4-49AC-9F97-4FD1E4DC8423

Q28205214-2CD56C54-E107-415A-BBD4-BDE402640600

Q28205214-38EF3981-4D9C-4314-912B-ABF5838BF744

Q28205214-48A8BB0E-03E3-4640-BC34-8B267E8AD7D2

Q28205214-4E92BCCD-707B-4926-B679-34A75D82ECBE

P304

Q28205214-1C4A1972-007D-4262-91F0-533B12AAB673

P31

Q28205214-05533BCA-132A-48C3-A22E-9F2CFA656D50

P3181

Q28205214-A568EAC0-6525-46C6-8803-0B860CCC1CE1

P356

Q28205214-51C37F5E-28CF-42B7-91C4-70DF133388D2

P407

Q28205214-DF69D7F2-3241-4517-B659-35F35AF24C36

P433

Q28205214-F3406550-1AF6-45AC-8403-4F464B553333

P478

Q28205214-A3F381CD-CBF7-4885-A57B-CE70E27695A8

P577

Q28205214-EB99DA62-8A87-49D8-B95D-BFFFE3AD98DB

P5875

Q28205214-31F31368-13DD-4161-94DF-42EB4171313F

P698

Q28205214-8E25CD2A-ABC8-4080-896C-744F081C7EF3

P3181

P356

J.1528-1157.2002.24501.X

P1433

P1476

Selective blockade of N-type calcium channels by levetiracetam

@en

P2093

E A Lukyanetz

http://www.w3.org/2001/XMLSchema#string

P G Kostyuk

http://www.w3.org/2001/XMLSchema#string

V M Shkryl

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs

Structure and regulation of voltage-gated Ca2+ channels

Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones

Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes

Altered expression and assembly of N-type calcium channel alpha1B and beta subunits in epileptic lethargic (lh/lh) mouse

Molecular and functional diversity of voltage-gated calcium channels.

Structure-activity relationships of omega-conotoxins at N-type voltage-sensitive calcium channels.

New antiepileptic drugs and non-pharmacological treatments.

Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies.

An assessment of levetiracetam as an anti-epileptic drug.

P304

9-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4381387

http://www.w3.org/2001/XMLSchema#string

P356

10.1046/J.1528-1157.2002.24501.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11484158

http://www.w3.org/2001/XMLSchema#string

P698

11879381

http://www.w3.org/2001/XMLSchema#string